TILT.NE stock at C$0.01 ahead of Mar 17 earnings: Meyka model C$0.02

TILT.NE stock trades at C$0.01 on the NEO exchange as TILT Holdings Inc. prepares to report earnings on 17 Mar 2026. Volume is elevated at 121,000 shares versus an average of 81,746.00, which raises the chance of a sharp move after the report. Investors will watch margins, cash flow and management commentary for guidance on the near-term recovery plan.

Earnings schedule and what TILT.NE stock faces

TILT.NE stock enters the market with an upcoming earnings announcement on 17 Mar 2026. The company last reported negative earnings per share of -0.35, and the sector is sensitive to cash-flow statements and regulatory updates. A beat on revenue or improved free cash flow could lift the microcap price quickly.

Expect volatility: the shares trade at C$0.01, a level where even a C$0.01 move equals 100.00% price change. That makes guidance and any balance sheet detail material for short-term traders.

TILT.NE stock valuation and recent financials

Valuation metrics show stress. TILT Holdings Inc. reports EPS -0.35 and a negative PE of -0.03. Market cap is approximately C$3,474,637.00 with 347,463,688.00 shares outstanding. Price to sales sits near 0.03, while enterprise value to sales is 1.16.

Working capital is weak; the current ratio is 0.24 and book value per share is -0.16. These figures point to tight liquidity and a dependency on cash generation or new financing to fund growth.

Technical and liquidity snapshot for TILT.NE stock

Price history is concentrated: day low and high are both C$0.01, year low C$0.01 and year high C$0.02 (year high listed C$0.015). The 50-day average price is C$0.01 and the 200-day average is C$0.01. Average volume is 81,746.00, and today’s volume of 121,000.00 implies relative volume 1.48.

Low absolute price versus reasonable volume creates rapid percentage swings. Traders should expect thin bid-ask behavior and potential liquidity gaps on large orders.

Meyka AI rates TILT.NE with a score out of 100

Meyka AI rates TILT.NE with a score of 70.98 out of 100 — Grade B+, Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

This internal grade weights growth, ratios and forecasts. It is informational only and not investment advice. Small-cap and microcap cannabis names remain high risk due to funding and regulatory variables.

Meyka AI’s forecast and TILT.NE stock price targets

Meyka AI’s forecast model projects a quarterly price of C$0.02, which implies 100.00% upside from the current C$0.01. The model-based base target is C$0.02, a conservative target is C$0.01, and a bullish scenario target is C$0.05.

Forecasts are model-based projections and not guarantees. Given the company’s cash metrics and negative EPS, upside depends on clear improvement in cash flow, favorable earnings commentary, or fresh financing.

Sector context, catalysts and key risks for TILT.NE stock

TILT Holdings operates in Healthcare and the Drug Manufacturers – Specialty & Generic industry. The broader healthcare sector average ROE is 2.76, while TILT shows negative margins and high operational leverage. Sector trends can mute or magnify company moves.

Key risks include weak liquidity, regulatory shifts, and capital markets access. Catalysts are better-than-expected earnings, cost cuts, or new distribution deals. For more background on public coverage and listings, see related market notes from StockAnalysis and recent market summaries on MarketWatch. For company filings and live data visit the firm page on Meyka AI: TILT.NE on Meyka.

Final Thoughts

TILT.NE stock trades at C$0.01 as TILT Holdings Inc. heads into its 17 Mar 2026 earnings report. The shares show elevated volume and stretched valuation metrics, including EPS -0.35 and a negative PE near -0.03, which reflect a company still in recovery. Meyka AI’s forecast model projects C$0.02, implying a 100.00% upside from the current price, while a conservative base target remains C$0.01 and a bull scenario sits at C$0.05. Our Meyka grade is B+ (70.98) and factors in benchmark, sector, growth, metrics and forecast signals. Investors should treat this as a high-risk, event-driven situation; a strong earnings beat or improved cash-flow guidance would validate the upside, while weak guidance or funding shortfalls could pressure the share price. Forecasts are model-based projections and not guarantees. Meyka AI, an AI-powered market analysis platform, will update this outlook after the earnings release.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.